Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2026
Total Assets: $957.0M
Liabilities Breakdown FY2026
Total Liabilities: $104.4M
Asset Breakdown
Total Assets: $957.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $902.1M | 94.3% |
| Accounts Receivable | $1.1M | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $443.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $53.3M | 5.6% |
Liabilities Breakdown
Total Liabilities: $104.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.5M | 7.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $96.9M | 92.8% |